Perrigo Q2 Earnings Beat Highlights Cost-Savings Traction Amid Persistent Sales Decline

What happened

Perrigo’s Q2 2026 results exceeded internal earnings expectations despite a continued sales decline driven by soft consumer self-care categories and retailer inventory reductions. The company maintained its full-year outlook, citing improving category trends, market-share gains, and expected second-half contributions from innovation and demand-generation efforts. This performance aligns with management’s Project Energize and Supply Chain Reinvention programs, which are beginning to support margins and offset top-line weakness. However, very high leverage (net debt/EBITDA ~7x) and the unresolved €1.64bn Irish tax dispute remain significant overhangs on the equity. While the earnings beat and maintained guidance suggest execution is on track, the sales slide underscores the challenging environment and the necessity of second-half catalysts to validate the turnaround thesis.

Implication

The better-than-expected earnings performance, driven by cost initiatives, indicates that management’s restructuring efforts are delivering, potentially supporting a gradual re-rating if margin gains persist. However, the ongoing sales decline reflects a tough consumer backdrop, and the stock’s deep discount to intrinsic value will only close if top-line trends stabilize and leverage trends lower. The maintained full-year outlook provides a near-term catalyst, with innovation and distribution gains expected in the second half, but execution risks remain elevated. Investors should monitor quarterly cash flow and interest coverage for evidence of deleveraging, while any adverse tax ruling could materially impair the equity. The thesis remains a high-risk, high-reward play that requires strict risk management and patience.

Thesis delta

The thesis that Perrigo is a potential buy, trading at distressed multiples, is reinforced by Q2 earnings exceeding internal targets and maintained guidance, which validate the cost-savings narrative. However, persistent sales declines and unresolved leverage and tax risks prevent a shift to a higher-conviction stance, keeping the investment case contingent on second-half execution.